pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

RNA Therapeutics Inc

updated 3mo ago
community read0 votes

🐶 often sniffed alongside

top 1
  • companyUniversity of Pennsylvania1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Preclinical: 1
1Preclinical
Preclinical
RNAT-89
Anemia in Chronic Kidney Disease (Renal Anemia)

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view RNA Therapeutics Inc jobs →

News

  • STAT+: ARPA-H funds biotechs working on custom RNA therapies
    Roche licenses a tri-specific antibody, new Trump deals may undercut its own goals, and other biotech news
    stat · 8d ago
  • ARPA-H awards $125M for manufacturing custom RNA therapies on demand
    The dream of making personalized genetic medicines at a moment’s notice just got a major infusion of funding from the federal government. Five groups were collectively awarded up to $125 million ...
    endpoints · 8d ago
  • From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech
    Whether it's looming tariff threats or the rise of China, you need a truly global view to navigate today's biopharma industry.
    fiercebiotech · 1mo ago
  • Fierce Biotech Fundraising Tracker '26: Encoded finagles $275M series F; Solstice rises with $225M
    The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
    fiercebiotech · 8mo ago
identifiers
source
globaldata
mentioned in
4news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?